The sucrose synthesis conversion rate has increased to 86 percent, with 14 grams of sucrose produced per liter of reaction liquid. As mentioned in the paper, a 10 cubic meter reactor, about the size ...

MIT researchers develop a wireless implant that detects low blood sugar and releases glucagon, offering a potential safety ...

In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a high-resolution metabolic "map" of how cells orchestrate glucose processing, ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

image: A new implantable device carries a reservoir of glucagon that can be stored under the skin and could save diabetes patients from dangerously low blood sugar. view more Credit: MIT CAMBRIDGE ...

Altimmune’s dual GLP-1/glucagon agonist pemvidutide helps resolve metabolic dysfunction-associated steatohepatitis—but does not appear to have significant therapeutic benefits on fibrosis associated ...

Glucagon-like peptide analogues or agonists are a new kind of drug in the treatment of type 2 diabetes that are given by injection under the skin. They regulate glucose levels by stimulating ...

Here we report a concise and modular synthesis of the complex triterpenoid glycinoeclepin A, a picomolar hatching stimulus for the notorious pest soybean cyst nematode. The synthesis features the ...

A scalable enzymatic process has been developed for the preparation of optically pure 3-bromo- or 3-methylsulfonyl-substituted l-phenylalanine (S)-1a–b, which serves as key intermediates in the ...